Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 21, 2025 10:50 ET | Source: Research and Markets

BK Virus Infection Market Trends, Strategies and Business Prospects 2025-2035 - Lack of FDA-Approved Drugs Spurs Innovation in BK Virus Treatment

Dublin, Nov. 21, 2025 (GLOBE NEWSWIRE) -- The "BK Virus Infection Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" has been added to ...
November 18, 2025 10:14 ET | Source: Research and Markets

Epstein Barr Virus Research Analysis Report 2025-2035: Market Led by AstrViracta, Atara, AlloVir, and Pierre Fabre as Antiviral and Immune-Modulating Therapy Innovation Accelerates

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Epstein Barr Virus Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been added to ...
November 13, 2025 08:45 ET | Source: Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals and Decoy Therapeutics Complete Merger

Salarius Pharmaceuticals and Decoy Therapeutics complete merger
September 04, 2025 07:54 ET | Source: Research and Markets

Trends & Strategies in the Thymalfasin Drugs Market 2025-2030: A Central Player in Value-Based Care and Personalized Medicine

Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The "Thymalfasin Drugs Market by Indication (Cancer, Hepatitis B, Hepatitis C), Route of Administration (Intramuscular Injection, Subcutaneous Injection),...
August 05, 2025 09:11 ET | Source: Research and Markets

Lassa Fever Market Analysis and Forecast Report 2025-2035 | Emerging Antivirals Target Lassa Fever with Promising Clinical Trials

Dublin, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The "Lassa Fever Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The...
April 10, 2025 09:55 ET | Source: Research and Markets

Antiviral Drugs Market Forecasts and Company Analysis 2025-2034 Featuring AbbVie, Aurobindo, BMS, Cipla, Dr. Reddy's, Gilead Sciences, GlaxoSmithKline, Janssen, Merck, Mylan, Pfizer, and Sun Pharma

Dublin, April 10, 2025 (GLOBE NEWSWIRE) -- The "Antiviral Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
March 05, 2025 10:38 ET | Source: Research and Markets

Ebola Fever Pipeline Market Landscape Report 2025: Emerging Therapies, Development Activities, Progress in Drug Development and Clinical Trials

Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Ebola Fever - Pipeline Insight, 2025" report has been added to ResearchAndMarkets.com's offering.This report captures an exhaustive analysis of the...
February 28, 2025 06:34 ET | Source: Research and Markets

Hepatitis B Therapeutics Competitive Landscape Report: 184 Molecules in the Pipeline - 1 Asset in Pre-registration Stage, 1 Asset in Phase III Development, and 36 Assets in Phase II Development

Dublin, Feb. 28, 2025 (GLOBE NEWSWIRE) -- The "Hepatitis B Therapeutics: Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven...
December 10, 2024 05:00 ET | Source: Global Market Insights Inc.

Veterinary Anti-infectives Market to hit USD 7.4 billion by 2032, says Global Market Insights Inc.

Selbyville, Delaware, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Veterinary anti-infectives market size was valued at USD 5.4 billion in 2023, is expected to expand at a CAGR of 3.5% from 2024 to 2032....
November 01, 2024 10:02 ET | Source: Research and Markets

Antiviral Drugs Market Poised for Growth with Impressive CAGR until 2030, Driven by Rising Disease Prevalence and Treatment Advances

Dublin, Nov. 01, 2024 (GLOBE NEWSWIRE) -- The "Antiviral Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. ...